About Incann.ch

Incann.ch is a Swiss-based, vertically-integrated company specializing in professional-grade medical cannabis cultivation and distribution. Their model combines top-tier indoor farming techniques with a modern online portal, delivering high-quality cannabis directly to patients and partners across Europe.

Now Part of Intra

As of recently, Incann.ch has become part of Intra, a major European cannabis platform. This integration consolidates their strengths—advanced cultivation, GMP-level quality controls, and digital access—under one broader umbrella, creating new synergies in production, research, and distribution.

The Market Opportunity (In Numbers)

• The global legal cannabis market (medical + recreational) is forecasted to reach $90 billion by 2026, with the European medical cannabis market expected to grow from $1.5 billion (2021) to over $5 billion by 2026.

(Source: industry analyst reports)

• Switzerland, as a leading pioneer in medical cannabis, is projected to grow at a CAGR of 20–25% in the coming years.

• Through Intra, Incann.ch gains enhanced market access, streamlined compliance, and strengthened ability to serve an expanding patient base across Europe.

What This Means

• Expanded Reach: Integration with Intra opens new European markets and expands B2B partnerships.

• Scaled Production: Leveraging Intra’s network amplifies their cultivation footprint while ensuring pharmaceutical-grade standards.

•Patient Impact: It enhances access to reliably produced medical cannabis for patients suffering from chronic or serious conditions.

Summary

By joining forces with Intra Consulting & Investment GmbH , Incann.ch takes a huge leap forward—uniting premium Swiss cultivation with a powerful European distribution engine. This positions them to capture a multi-billion-dollar medical cannabis opportunity, while staying committed to quality, compliance, and patient care.